Fedde KN, Whyte MP (1990) Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5′-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. Am J Hum Genet 47(5):767–775
CAS PubMed PubMed Central Google Scholar
Addison WN, Azari F, Sorensen ES, Kaartinen MT, McKee MD (2007) Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem 282(21):15872–15883
Article CAS PubMed Google Scholar
Fleisch H (1981) Diphosphonates: history and mechanisms of action. Metab Bone Dis Relat Res 3(4-5):279–287
Article CAS PubMed Google Scholar
Whyte MP (2010) Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 1192:190–200
Article CAS PubMed Google Scholar
Wilson MP, Plecko B, Mills PB, Clayton PT (2019) Disorders affecting vitamin B(6) metabolism. J Inherit Metab Dis 42(4):629–646
Article CAS PubMed Google Scholar
Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Burgi S, Sergi C, Ryan L et al (2007) Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 40(6):1655–1661
Article CAS PubMed Google Scholar
Nunes ME (1993) Hypophosphatasia. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, LJH B et al (eds) GeneReviews((R)), Seattle (WA)
Bianchi ML (2015) Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int 26(12):2743–2757
Article CAS PubMed Google Scholar
Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC et al (2015) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone (New York, NY) 75:229–239
Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N et al (2021) Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet 29(2):289–299
Article CAS PubMed Google Scholar
Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA (2013) Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54(1):21–27
Article CAS PubMed Google Scholar
Shapiro JR, Lewiecki EM (2017) Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res 32(10):1977–1980
Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S et al (2019) Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int 30(9):1713–1722
Article CAS PubMed Google Scholar
Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ et al (2019) Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol 7(2):93–105
Article CAS PubMed Google Scholar
Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE et al (2019) Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone 121:149–162
Article CAS PubMed Google Scholar
Klidaras P, Severt J, Aggers D, Payne J, Miller PD, Ing SW (2018) Fracture healing in two adult patients with hypophosphatasia After Asfotase Alfa Therapy. JBMR Plus 2(5):304–307
Article CAS PubMed PubMed Central Google Scholar
Lefever E, Witters P, Gielen E, Vanclooster A, Meersseman W, Morava E et al (2020) Hypophosphatasia in adults: clinical spectrum and its association with genetics and metabolic substrates. J Clin Densitom 23(3):340–348
Vaisman DN, McCarthy AD, Cortizo AM (2005) Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations. Biol Trace Elem Res 104(2):131–140. https://doi.org/10.1385/BTER:104:2:131
Article CAS PubMed Google Scholar
Chuck AJ, Pattrick MG, Hamilton E, Wilson R, Doherty M (1989) Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis 48(7):571–576
Article CAS PubMed PubMed Central Google Scholar
Guañabens N, Mumm S, Möller I, González-Roca E, Peris P, Demertzis JL et al (2014) Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res 29(4):929–934
Conti F, Ciullini L, Pugliese G (2017) Hypophosphatasia: clinical manifestation and burden of disease in adult patients. Clin Cases Miner Bone Metab 14(2):230–234
Article PubMed PubMed Central Google Scholar
Whyte MP (2016) Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233–246
Article CAS PubMed Google Scholar
Millan JL, Plotkin H (2012) Hypophosphatasia - pathophysiology and treatment. Actual osteol 8(3):164–182
PubMed PubMed Central Google Scholar
Kitaoka T, Tajima T, Nagasaki K, Kikuchi T, Yamamoto K, Michigami T et al (2017) Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: results from a Japanese clinical trial. Clin Endocrinol (Oxf) 87(1):10–19
Article CAS PubMed Google Scholar
Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D et al (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366(10):904–913
Article CAS PubMed Google Scholar
Seefried L, Kishnani PS, Moseley S, Denker AE, Watsky E, Whyte MP et al (2021) Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia. Bone 142:115664
Article CAS PubMed Google Scholar
Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A et al (2016) Asfotase alfa therapy for children with hypophosphatasia. JCI insight 1(9):e85971–e85971
Article PubMed PubMed Central Google Scholar
Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W et al (2017) Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab 122(1-2):4–17
Comments (0)